> Immunovaccine is collaborating with the NIH to develop DepoVax-based next-generation biodefense vaccines against threatening biological agents. Immunovaccine release
> BioDiem has licensed its live attenuated influenza virus to Chinese company Changchun BCHT Biotechnology for the Chinese private sector market. BioDiem release
> Medicago has received the fourth milestone payment of $3.56 million from the Defense Advanced Research Projects Agency for manufacture of its plant-expressed VLP vaccines. Medicago release
> Sex workers resistant to HIV could help researchers find a new route to an AIDS vaccine. Article
> Combining a PSA vaccine with a monoclonal antibody in prostate cancer did not increase adverse effects in a Phase I trial. Abstract
> OncoPep has signed an agreement with Dana‐Farber Cancer Institute to license its multi‐peptide therapeutic cancer vaccine technology. OncoPep release
> A U.S. hospital has started a clinical trial for a brain tumor vaccine. Article
> A vaccine shows potential to protect against bacterial infection of orthopedic implants. ORS release
And Finally... PaxVax has expanded its executive management team at C-level with a new COO, CTO and CSO. PaxVax release